The Department of Pediatrics is pleased to announce the appointment of Dr. Lisa Giulino Roth as the John D. and Lili R. Bussel Professor in Pediatric Hematology effective April 1, 2025.
This professorship, made possible by the generosity of the Bussel Family, recognizes Dr. Roth’s leadership in hematology/oncology research and significant contributions to both understanding the underlying mechanisms of children and young adults with lymphoma and developing innovative therapeutic strategies. Her accomplishments and commitment as leader and mentor bring distinction to Weill Cornell Medicine.
Dr. James Bussel, on behalf of the Bussel family, echoes Dr. Roth’s praises in this well-deserved accolade “It is a great honor and pleasure for Lisa Roth to be named to the Bussel Family Professorship. I first worked with her when she was a fourth-year student rotating with us from NYU and it was so obvious from day one how smart, creative and hard working she is. Her career has been meteoric based on her ground-breaking work in lymphoma reaching beyond Pediatrics to the Adolescent-Young-Adult age group. I look forward with great anticipation to her future discoveries and to her mentorship of Nitya Gulati as well.”
Dr. Roth is the Director of Pediatric Oncology, Associate Vice Chair for Translational Research, co-director of the Cancer Therapeutics Program for the Meyer Cancer Center and Professor in the Departments of Pediatrics, Medicine and Pathology and Laboratory Medicine at Weill Cornell Medicine. She is also an Attending Pediatrician at New York-Presbyterian Hospital/Weill Cornell Medical Center. From 2013 through 2019, Dr. Roth served as the Charles, Lillian and Betty Neuwirth Clinical Scholar in Pediatric Oncology.
Specializing in treating children, adolescents and young adults with lymphoma, Dr. Roth holds several national leadership roles including Vice Chair of the Hodgkin Lymphoma Committee in the Children’s Oncology Group and member of the scientific advisory board for the Lymphoma Research Foundation.
Dr. Roth’s research focuses on identifying new treatments for children, adolescents, and young adults with lymphoma. Her work has revealed genomic alterations in these lymphomas and developed novel targeted treatment strategies. Her laboratory work is closely tied to her clinical research where she is leading several national clinical trials focused on advancing therapy for children, adolescents, and young adults with lymphoma. Dr. Roth has been recognized for her work through awards including an NIH R37 MERIT Award, an NIH U01 award, an ASCI Young Investigator Award, ASCI membership, and an ASH Scholar Award.
She received her medical degree from New York University School of Medicine and completed her residency at New York-Presbyterian/Weill Cornell and her fellowship in pediatric hematology/oncology at Memorial Sloan-Kettering Cancer Center and Weill-Cornell/New York-Presbyterian, where she served as chief fellow.